{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:14:50Z","timestamp":1740147290662,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002457","name":"Chosun University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13256-016-0915-6","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T22:04:28Z","timestamp":1464732268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Young-min","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-yeong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Gon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"915_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000338393","volume":"22","author":"MJ Duffy","year":"2013","unstructured":"Duffy MJ. Tumor markers in clinical practice: a review focusing on common solid cancers. Med Princ Pract. 2013;22:4\u201311.","journal-title":"Med Princ Pract."},{"key":"915_CR2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer","year":"2012","unstructured":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908\u201343.","journal-title":"J Hepatol"},{"key":"915_CR3","first-page":"1747","volume":"23","author":"M Soresi","year":"2003","unstructured":"Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res. 2003;23:1747\u201353.","journal-title":"Anticancer Res."},{"key":"915_CR4","first-page":"153","volume":"10","author":"AM Crissien","year":"2014","unstructured":"Crissien AM, Frenette C. Current management of hepatocellular carcinoma. Gastroenterol Hepatol (NY). 2014;10:153\u201361.","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"915_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","volume":"29","author":"M Kudo","year":"2011","unstructured":"Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29:339\u201364.","journal-title":"Dig Dis."},{"key":"915_CR6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1478-3231.2012.02792.x","volume":"32","author":"PP Song","year":"2012","unstructured":"Song PP, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, et al. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int. 2012;32:1053\u201363.","journal-title":"Liver Int."},{"key":"915_CR7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.5858\/2007-131-1267-AOOTGC","volume":"131","author":"A Bahrami","year":"2007","unstructured":"Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med. 2007;131:1267\u201380.","journal-title":"Arch Pathol Lab Med."},{"key":"915_CR8","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/PAS.0b013e3181f0a873","volume":"34","author":"X Liu","year":"2010","unstructured":"Liu X, Cheng Y, Sheng W, Lu H, Xu X, Xu Y, et al. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol. 2010;34:1465\u201371.","journal-title":"Am J Surg Pathol."},{"key":"915_CR9","first-page":"123743","volume":"2011","author":"PP Veek van der","year":"2011","unstructured":"van der Veek PP, de Vos Tot Nederveen Cappel WH, Langers AM, van Hoek B. Two patients with extremely elevated tumor markers: where is the malignancy? Gastroenterol Res Pract. 2011;2011:123743. doi: 10.1155\/2011\/123743 .","journal-title":"Gastroenterol Res Pract"},{"key":"915_CR10","first-page":"400","volume":"16","author":"SL Han","year":"2010","unstructured":"Han SL, Wu XL, Jia ZR, Wang PF. Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein. Hong Kong Med J. 2010;16:400\u20132.","journal-title":"Hong Kong Med J."},{"key":"915_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3904\/kjim.2005.20.1.80","volume":"20","author":"JS Bae","year":"2005","unstructured":"Bae JS, Park SJ, Park KB, Paik SY, Ryu JK, Choi CK, et al. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma. Korean J Intern Med. 2005;20:80\u20135.","journal-title":"Korean J Intern Med."},{"key":"915_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004836-200305000-00017","volume":"36","author":"FY Yao","year":"2003","unstructured":"Yao FY. Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis. J Clin Gastroenterol. 2003;36:440\u20132.","journal-title":"J Clin Gastroenterol."},{"key":"915_CR13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jceh.2013.02.246","volume":"3","author":"M Patil","year":"2013","unstructured":"Patil M, Sheth KA, Adarsh CK. Elevated alpha fetoprotein, no hepatocellular carcinoma. J Clin Exp Hepatol. 2013;3:162\u20134.","journal-title":"J Clin Exp Hepatol."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-0915-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T22:08:46Z","timestamp":1656626926000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-0915-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-0915-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2016,6,1]]},"article-number":"140"}}